Clinical trial planned

Clinical trial planned in collaboration with the University of Gothenberg

RSP Systems is initiating an explorative study in collaboration with Professor Per-Anders Jansson at Sahlgrenska Academy in Gothenburg. People with Type 1 diabetes, as well as people with insulin-requiring type 2 diabetes, are eligible to participate. In addition to investigating the improvement of technology accuracy, the study will contribute to the understanding of the dynamics between conservative blood glucose values and interstitial glucose values, the latter being the target of RSP technology.

The Laboratory and Professor Per-Anders Jansson are focused on metabolic disorders and diabetes. The laboratory supports and promotes research in translational medicines to improve health and to benefit society. Per-Anders Jansson is highly experienced within the field of diabetes and his expertise will greatly contribute to the explorative studies, supporting the development of the our non-invasive glucose monitoring technology.


Share on facebook
Share on twitter
Share on linkedin

More news

New Mechanical Design Engineer We have been enriched once again with incredible talent, adding Thøger Sørensen to work as our first full-time mechanical …

RSP Systems A/S, the technology leader within non-invasive glucose monitoring, announced the completion of a US$5.45 million Series A funding. The round …

New CEO Appointed

We are delighted to announce that the Board has appointed Anders Weber CEO of RSP Systems early this month. Anders has been …